Skip to main content

Table 1 Summary table of the main tumour results

From: Biokinetic and dosimetric aspects of 64CuCl2 in human prostate cancer: possible theranostic implications

 

Local recurrences

Lymph node metastasis

Bone metastasis

p Local vs lymph node

p Local vs bone

p Lymph node vs Bone

T1/2eff (T1/2biol) (h)

8.8 ± 1.1 (28.7 ± 3.6)

10.2 ± 1.7 (51.8 ± 8.6)

9.0 ± 0.4 (30.9 ± 1.4)

0.003

0.9

0.4

SUVmean at 1 h

3.1 ± 1.1

5.2 ± 2.1

4.3 ± 0.9

< 0.001

0.003

0.8

SUVmax at 1 h

4.7 ± 2.4

6.8 ± 4.3

6.8 ± 2.9

0.02

0.03

0.5

Ï„ (h)

1.1E-2 ± 2.4E-2

6.1E-3 ± 7.8E-3

6.4E-3 ± 1.0E-2

0.3

0.2

0.8

D/A (mGy/MBq)

3.71E-2 ± 1.87E-2

9.65E-2 ± 5.95E-2

5.40E-2 ± 3.86E-2

< 0.001

0.1

0.6

  1. Values are reported as mean ± standard deviation. Statistically significant differences (p < 0.05) are in bold